Last updated 2026-07-20
Portfolio
0
in our dataset
Rounds participated
0
Rounds led
0
Rounds' value
—
total disclosed, rounds participated
Stages
—
About
NeuroTechnology Investors (NTI) is a venture capital firm that leverages a network of physician leaders to identify, invest in, and co-develop promising medical technologies throughout their development lifecycle, from concept to clinical utility. The firm focuses on neurotechnology solutions that address the limitations of the human body.
Portfolio
No portfolio companies in this dataset yet.
Investment activity
1 portfolio exit on record.
Portfolio by sector
Health Tech & Life Sciences1
Q&A
- What is Neuro Technology Investors' most notable exit?
- Neuro Technology Investors had a notable exit with EndoStream Medical, which was acquired by.
- Which sectors does Neuro Technology Investors focus on?
- Neuro Technology Investors shows a concentration in the Health Tech &.
- Can you name a key portfolio company for Neuro Technology Investors?
- A key portfolio company for Neuro Technology Investors is EndoStream Medical, which focuses on.
- What is the typical investment range for Neuro Technology Investors?
- Neuro Technology Investors typically invests between $14.6K and $1.89M.
- When was Neuro Technology Investors most recently active in new investments?
- Neuro Technology Investors' most recent recorded investment activity for a new portfolio company was in February 2018.
- What funding stages does Neuro Technology Investors participate in?
- Neuro Technology Investors has participated in Seed and A Round funding stages.
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
Identifiers & details
| Founded | 2016 |
|---|